Over the course of the projected period, market expansion is anticipated to be fueled by the leading players’ increased adoption of inorganic growth tactics including collaborations and agreements. For instance, in May 2021, Vituity, a physician-led and-owned healthcare delivery organisation, announced a strategic partnership with Inflect Health, a new nationwide, multispecialty investment and innovation hub. Vituity is a medical technology company focused on improving outcomes for stroke and brain injury patients. The medical co-founders of Sense Diagnostics, LLC, who work in emergency medicine, neurology, and neurocritical care, discovered a critical need and filled it.
Request Sample Report @
https://www.coherentmarketinsights.com/insight/request-sample/5330
Acandis GmbH, a manufacturer of medical devices, declared in May 2021 that their APERIO Hybrid Thrombectomy Device had been granted European Conformitè Europenne (CE) Mark approval. When a patient has been diagnosed with an ischemic stroke caused by an intracranial blockage, this thrombectomy device is utilised to restore arterial flow. In order to increase safety and control, this device incorporates a powerful hybrid cell architecture.
Assistance Publique – Hôpitaux de Paris, a university hospital, in partnership with the French Ministry of Health, W. L. Gore & Associates, Inc., Abbott, a multinational manufacturer of medical devices and healthcare products, Occlutech International AB Centre, a maker of cardiac occlusion devices, and Hospitalier St. Anne, a hospital, started a clinical research study in June 2022 for the transcatheter PFO (patent foramen ovale) closure procedure to
Furthermore, over the course of the projected period, the prevalence of ischemic stroke is anticipated to rise. For instance, a stroke occurs in the United States every 40 seconds, affecting more than 795,000 people annually, with ischemic stroke accounting for nearly 87% of all strokes, according to a fact sheet from the Centers for Disease Control and Prevention (CDC) that was published in April 2022.
The financial standing of companies in all industries, including the private healthcare sector, has been harmed by the COVID-19 epidemic and lockdowns in numerous nations throughout the world.
Due to the risk of COVID-19 and the risk of ischemic stroke among Medicare members aged 65 and older, the COVID-19 pandemic had a considerable impact on the market for ischemic neurological interventional medical devices. For instance, according to a paper published in February 2022 in the Journal for Clinical Neurology Research, the risk of ischemic stroke among the elderly population is 10 times higher in the first three days following diagnosis of COVID-19 than it is in the control period, and it appears that the risk associated with COVID-19 is higher in people aged 65 to 74 and in people who have never had a stroke.
Download PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/5330
Due to the increasing adoption of strategies by the key players for conducting research activities of neurological interventional medical devices, such as the expansion of manufacturing facilities and support launches, the global market for ischemic neurological interventional medical devices is anticipated to display a CAGR of 5.6% during the forecast period. For instance, Sense Diagnostics, LLC made a sizable investment in the expansion of its manufacturing and development locations in November 2021 and provided significant automation benefits to serve the projected demand for the ischemia neurological interventional medical devices.
Due to technological improvements and different theoretic advancements, the mechanical thrombectomy segment is anticipated to dominate the global ischemic neurological interventional medical devices market throughout the course of the forecast period. A medical technology startup called Imperative Care announced the release of their ZOOM POD aspiration tubing in February 2022 with the goal of improving stroke care. For patients with ischemic stroke, it allows for a quicker time to clot capture during crucial mechanical thrombectomy treatments. The distance from aspiration is shortened by the Zoom POD’s integration with the aspiration tubing.
Due to an increase in new launches and product approval, North America is anticipated to hold the highest market share among the regions in the global market for ischemia neurological interventional medical devices during the forecast period. For instance, the latest addition to Penumbra, Inc.’s full Penumbra System, the RED 62 Reperfusion Catheter, received FDA 510(k) clearance and became commercially available in June 2021. Penumbra, Inc. is a worldwide healthcare company focused on cutting-edge therapeutics. Together with Penumbra ENGINE, RED 62 is made to navigate intricate distal artery anatomy and deliver forceful aspiration for the removal of blood clots in ischemic stroke patients with big vessel occlusions.
The market for ischemia neurological interventional medical devices is dominated by companies like Integer Holdings Corporation, and Wallaby Medical, Stryker, KANEKA COPORATION, Johnson & Johnson Services Inc., MicroPort Scientific Corporation, Penumbra, Inc., W. L. Gore & Associates, Inc., Medtronic, Imperative Care, Sense Neuro, Terumo Corporation, VESALIO, LLC, and 880 Medical, LLC are just a few of the companies that make up the industry.
Reasons to buy this Ischemic Neurological Interventional Medical Devices Market Report
☑ It attempts an analysis of the competing scenario.
☑ The current and exceptional product revenue market.
☑ An in-depth data on the regional investigation and competitive landscape structure.
☑ It benefits in creating an awareness of the important key product segments.
☑ The marketing strategies, opportunities, and development factors are explained.
☑ Ischemic Neurological Interventional Medical Devices market size estimation and recent advancements in the industry are explained.
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/5330
Table of Content
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Device Type
- Market Snapshot, By Procedure Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Regulatory Scenario
- PEST Analysis
- Market Dynamics
- Global Ischemic Neurological Interventional Medical Devices Market– Impact of Coronavirus (COVID-19) Pandemic
- Economic Impact
- Impact on Clinical Trials and Drug Development
- Government Initiatives
- Global Ischemic Neurological Interventional Medical Devices Market, By Device Type, 2017 – 2030, (US$ Mn.)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Neurothrombectomy Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Aspiration/Suction Catheters
- Clot Retrievers
- Snare-like devices
- Others (Lasers, etc.)
- Embolization Stents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Stenting System
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Overview
- Global Ischemic Neurological Interventional Medical Devices Market, By Procedure Type, 2017 – 2030, (US$ Mn.)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Mechanical Thrombectomy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Carotid Endarterectomy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Stenting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Overview
- Global Ischemic Neurological Interventional Medical Devices Market, By End User, 2017 – 2030, (US$ Mn.)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn.)
- Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn.)
- Ambulatory Surgical Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn.)
- Overview
- Global Ischemic Neurological Interventional Medical Devices Market, By Region, 2017 – 2030, (US$ Mn.)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2030
- North America
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Stryker
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Johnson & Johnson Services, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Penumbra, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Medtronic
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- VESALIO, LLC.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sense Neuro
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- 880 Medical, LLC.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Terumo Corporation.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Imperative Care.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- W. L. Gore & Associate, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- MicroPort Scientific Corporation.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- KANEKA COPORATION.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Integer Holdings Corporation.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Wallaby Medical.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Stryker
- Section
- Research Methodology
- About Us
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact us:
Mr. Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com